| Giannattasio A, Barbarino A, Lo Vecchio A, et al.
Effects of Antiretroviral Drug Recall on Perception of Therapy Benefits and on Adherence to Antiretroviral Treatment in HIV-Infected Children. [JOURNAL ARTICLE]
Curr HIV Res 2009 Sep; 7(5):468-472.
Abstract | Full Citation | Find Related Articles | | Damle BD, Uderman H, Biswas P, et al.
Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):682-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Paredes R, Cheng I, Kuritzkes DR, et al.
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. [JOURNAL ARTICLE]
AIDS 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Saitoh A, Capparelli E, Aweeka F, et al.
CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1-Infected Children Receiving Highly Active Antiretroviral Therapy. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov 3.
Abstract | Full Citation | Find Related Articles | | Walker VE, Casciano DA, Tweats DJ
The Viracept-EMS case: impact and outlook. [Journal Article, Research Support, Non-U.S. Gov't]
Toxicol Lett 2009 Nov 12; 190(3):333-9.
Abstract | Full Citation | Find Related Articles | | Sugioka N, Haraya K, Fukushima K, et al.
Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. [JOURNAL ARTICLE]
Biopharm Drug Dispos 2009 Oct 27.
Abstract | Full Citation | | Gocke E, Wall M
In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):298-302.
Abstract | Full Citation | | Gocke E, Bürgin H, Müller L, et al.
Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):254-265.
Abstract | Full Citation | | Gerber C, Toelle HG
What happened: The chemistry side of the incident with EMS contamination in Viracept tablets. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):248-253.
Abstract | Full Citation | | Müller L, Singer T
EMS in Viracept-The course of events in 2007 and 2008 from the non-clinical safety point of view. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):243-247.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
